Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)
CNY 28.51
(-2.16%)
CNY 28.51
(-2.16%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 790.99 Million CNY | 17.98% |
| 2022 | 624.29 Million CNY | -13.15% |
| 2021 | 718.78 Million CNY | 30.05% |
| 2020 | 552.71 Million CNY | -46.41% |
| 2019 | 1.03 Billion CNY | 0.73% |
| 2018 | 1.02 Billion CNY | 2.53% |
| 2017 | 998.69 Million CNY | 11.79% |
| 2016 | 893.35 Million CNY | 8.79% |
| 2015 | 821.19 Million CNY | 13.82% |
| 2014 | 721.47 Million CNY | 4.92% |
| 2013 | 687.67 Million CNY | 23.65% |
| 2012 | 556.13 Million CNY | 27.32% |
| 2011 | 436.8 Million CNY | 38.98% |
| 2010 | 314.29 Million CNY | 41.5% |
| 2009 | 222.11 Million CNY | 54.19% |
| 2008 | 144.05 Million CNY | 91.95% |
| 2007 | 75.04 Million CNY | 216.36% |
| 2006 | 23.72 Million CNY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 203.57 Million CNY | -7.83% |
| 2024 Q2 | 218.48 Million CNY | 7.33% |
| 2024 Q3 | 270.6 Million CNY | 23.86% |
| 2023 Q1 | 150.27 Million CNY | -35.53% |
| 2023 Q3 | 203.69 Million CNY | -2.26% |
| 2023 FY | 736.51 Million CNY | 17.98% |
| 2023 Q4 | 220.85 Million CNY | 8.43% |
| 2023 Q2 | 208.4 Million CNY | 38.68% |
| 2022 FY | 624.29 Million CNY | -13.15% |
| 2022 Q4 | 233.07 Million CNY | 68.93% |
| 2022 Q3 | 137.97 Million CNY | 3.16% |
| 2022 Q2 | 133.74 Million CNY | 11.92% |
| 2022 Q1 | 119.49 Million CNY | -47.3% |
| 2021 Q3 | 113.32 Million CNY | -54.71% |
| 2021 Q2 | 250.19 Million CNY | 94.66% |
| 2021 Q1 | 128.52 Million CNY | 237.85% |
| 2021 FY | 718.78 Million CNY | 30.05% |
| 2021 Q4 | 226.74 Million CNY | 100.09% |
| 2020 Q2 | 261.58 Million CNY | 479.28% |
| 2020 Q3 | 207.93 Million CNY | -20.51% |
| 2020 Q4 | 38.04 Million CNY | -81.7% |
| 2020 FY | 552.71 Million CNY | -46.41% |
| 2020 Q1 | 45.15 Million CNY | -88.04% |
| 2019 Q2 | 385.04 Million CNY | 506.21% |
| 2019 FY | 1.03 Billion CNY | 0.73% |
| 2019 Q4 | 377.63 Million CNY | 84.01% |
| 2019 Q3 | 205.22 Million CNY | -46.7% |
| 2019 Q1 | 63.51 Million CNY | 0.0% |
| 2018 FY | 1.02 Billion CNY | 2.53% |
| 2017 FY | 998.69 Million CNY | 11.79% |
| 2016 FY | 893.35 Million CNY | 8.79% |
| 2015 FY | 821.19 Million CNY | 13.82% |
| 2014 FY | 721.47 Million CNY | 4.92% |
| 2013 Q1 | 145.95 Million CNY | 8.8% |
| 2013 Q2 | 166.64 Million CNY | 14.18% |
| 2013 Q3 | 188.24 Million CNY | 12.96% |
| 2013 FY | 687.67 Million CNY | 23.65% |
| 2012 Q2 | 124.83 Million CNY | -7.75% |
| 2012 FY | 556.13 Million CNY | 27.32% |
| 2012 Q4 | 134.14 Million CNY | -17.11% |
| 2012 Q3 | 161.83 Million CNY | 29.63% |
| 2012 Q1 | 135.32 Million CNY | 25.7% |
| 2011 Q2 | 111.01 Million CNY | 37.26% |
| 2011 Q4 | 107.65 Million CNY | -21.57% |
| 2011 Q1 | 80.87 Million CNY | -9.56% |
| 2011 FY | 436.8 Million CNY | 38.98% |
| 2011 Q3 | 137.26 Million CNY | 23.65% |
| 2010 Q1 | 58.64 Million CNY | 0.0% |
| 2010 Q2 | 76.74 Million CNY | 30.87% |
| 2010 Q4 | 89.42 Million CNY | -0.06% |
| 2010 FY | 314.29 Million CNY | 41.5% |
| 2010 Q3 | 89.48 Million CNY | 16.6% |
| 2009 FY | 222.11 Million CNY | 54.19% |
| 2008 FY | 144.05 Million CNY | 91.95% |
| 2007 FY | 75.04 Million CNY | 216.36% |
| 2006 FY | 23.72 Million CNY | 0.0% |